We profiled GBM Treg cells for expression of co-inhibitory/activating receptors by flow cytometry (Supplementary Fig. 6), and found that GITR showed the highest expression in intratumoral GBM Treg cells, irrespective of ICB treatment (Supplementary Fig. 6a). The gene discussed is TNFRSF18; the disease is glioblastoma.